Wall Street analysts expect Proto Labs Inc (NYSE:PRLB) to announce sales of $112.52 million for the current quarter, Zacks reports. Three analysts have provided estimates for Proto Labs’ earnings. The highest sales estimate is $112.55 million and the lowest is $112.50 million. Proto Labs posted sales of $88.11 million during the same quarter last year, which suggests a positive year-over-year growth rate of 27.7%. The firm is expected to report its next earnings report on Thursday, October 25th.

On average, analysts expect that Proto Labs will report full-year sales of $445.19 million for the current fiscal year, with estimates ranging from $445.00 million to $445.46 million. For the next fiscal year, analysts anticipate that the business will post sales of $507.71 million per share, with estimates ranging from $504.04 million to $511.50 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Proto Labs.

Proto Labs (NYSE:PRLB) last released its quarterly earnings data on Thursday, July 26th. The industrial products company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.72 by $0.01. The firm had revenue of $109.65 million during the quarter, compared to analyst estimates of $110.46 million. Proto Labs had a return on equity of 13.55% and a net margin of 15.98%. The business’s quarterly revenue was up 33.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 earnings per share.

Separately, Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $137.00 price objective for the company in a research note on Friday, August 3rd. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Proto Labs presently has an average rating of “Buy” and a consensus target price of $104.33.

Shares of NYSE:PRLB traded down $1.65 during trading on Tuesday, reaching $161.50. 5,621 shares of the company traded hands, compared to its average volume of 137,221. The firm has a market cap of $4.33 billion, a PE ratio of 84.79, a price-to-earnings-growth ratio of 2.88 and a beta of 1.22. Proto Labs has a 52-week low of $73.30 and a 52-week high of $166.60.

In related news, VP Robert Bodor sold 4,435 shares of the firm’s stock in a transaction on Thursday, August 30th. The stock was sold at an average price of $150.20, for a total value of $666,137.00. Following the completion of the sale, the vice president now owns 23,283 shares of the company’s stock, valued at $3,497,106.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO John Way sold 3,912 shares of the firm’s stock in a transaction on Friday, August 24th. The stock was sold at an average price of $145.79, for a total value of $570,330.48. Following the completion of the sale, the chief financial officer now directly owns 29,415 shares of the company’s stock, valued at approximately $4,288,412.85. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,934 shares of company stock valued at $2,390,641. Insiders own 0.64% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the stock. BlackRock Inc. lifted its stake in Proto Labs by 13.5% in the second quarter. BlackRock Inc. now owns 3,580,804 shares of the industrial products company’s stock worth $425,936,000 after acquiring an additional 425,901 shares during the period. Janus Henderson Group PLC lifted its stake in Proto Labs by 1.1% in the second quarter. Janus Henderson Group PLC now owns 1,103,727 shares of the industrial products company’s stock worth $131,288,000 after acquiring an additional 11,783 shares during the period. Conestoga Capital Advisors LLC raised its holdings in Proto Labs by 6.3% in the second quarter. Conestoga Capital Advisors LLC now owns 605,631 shares of the industrial products company’s stock worth $72,040,000 after purchasing an additional 35,969 shares in the last quarter. Northern Trust Corp raised its holdings in Proto Labs by 7.1% in the second quarter. Northern Trust Corp now owns 408,438 shares of the industrial products company’s stock worth $48,583,000 after purchasing an additional 27,051 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Proto Labs by 3.0% in the second quarter. Bank of New York Mellon Corp now owns 339,448 shares of the industrial products company’s stock worth $40,378,000 after purchasing an additional 9,920 shares in the last quarter. 96.66% of the stock is owned by institutional investors.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce enabled digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets.

Read More: Moving Average (MA)

Get a free copy of the Zacks research report on Proto Labs (PRLB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.